标题
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-06-10
DOI
10.3389/fonc.2021.673276
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
- (2021) Paula Schmidt et al. Frontiers in Immunology
- Percentage of Natural Killer (NK) Cells in Peripheral Blood Is Associated with Prognosis in Patients with Gastric Cancer: A Retrospective Study from a Single Center
- (2021) Ming-zhi Xie et al. MEDICAL SCIENCE MONITOR
- Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
- (2020) Bihui Cao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Non‐clinical efficacy, safety, and stable clinical cell processing of iPSC‐derived anti‐GPC3 CAR‐expressing NK/ILC cells
- (2020) Tatsuki Ueda et al. CANCER SCIENCE
- The therapeutic landscape for cells engineered with chimeric antigen receptors
- (2020) Matthew MacKay et al. NATURE BIOTECHNOLOGY
- Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
- (2020) Zhiwei Hu Scientific Reports
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
- (2020) Ombretta Melaiu et al. Frontiers in Immunology
- Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry
- (2020) Genny Del Zotto et al. CYTOMETRY PART A
- Harnessing natural killer cells for the treatment of ovarian cancer
- (2020) Janneke S. Hoogstad-van Evert et al. GYNECOLOGIC ONCOLOGY
- Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
- (2020) Helen Kotanides et al. MOLECULAR CANCER THERAPEUTICS
- Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
- (2020) Kevin O. McNerney et al. Frontiers in Immunology
- Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
- (2020) Yan Liu et al. CELL PROLIFERATION
- CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
- (2020) Kyle B. Lupo et al. Journal of Hematology & Oncology
- A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis
- (2020) Chengui Lu et al. MOLECULAR IMMUNOLOGY
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Genome-wide piggyBac transposon-based mutagenesis and quantitative insertion-site analysis in haploid Candida species
- (2020) Zeyao Li et al. Nature Protocols
- Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
- (2020) Yvette Robbins et al. eLife
- Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
- (2020) Shuo Yang et al. Frontiers in Pharmacology
- Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
- (2020) Cai Zhang et al. Frontiers in Immunology
- Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
- (2020) Fabio Morandi et al. Cells
- Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell
- (2020) Wahyu Widowati et al. African Health Sciences
- Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
- (2020) Hsiang-chi Tseng et al. Nature Communications
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
- (2020) Ahmet Yilmaz et al. Journal of Hematology & Oncology
- The role of natural killer cell in gastrointestinal cancer: killer or helper
- (2020) Feixue Wang et al. ONCOGENE
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model
- (2019) Jiantai Qiu et al. Cancers
- Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
- (2019) Benjamin Heyman et al. Cancers
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
- (2019) Yingxi Xu et al. Journal of Hematology & Oncology
- Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
- (2019) Xiang Ao et al. JOURNAL OF IMMUNOTHERAPY
- Development of c‑MET‑specific chimeric antigen receptor‑engineered natural killer cells with cytotoxic effects on human liver cancer HepG2 cells
- (2019) Bing Liu et al. Molecular Medicine Reports
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges
- (2019) Luyao Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- HER2-specific chimeric antigen receptor-engineered natural killer cells combined with apatinib for the treatment of gastric cancer
- (2019) Xian Wu et al. BULLETIN DU CANCER
- Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer
- (2019) Ramesh B. Batchu et al. SURGERY
- Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells
- (2019) L. Herrera et al. Scientific Reports
- Harnessing NK Cells for Cancer Treatment
- (2019) Paola Minetto et al. Frontiers in Immunology
- CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
- (2019) Yu Yang Ng et al. Molecular Therapy-Oncolytics
- Immune Therapy for Liver Cancers
- (2019) Marc Hilmi et al. Cancers
- Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells
- (2018) Tina Nham et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
- (2018) Min Yu et al. MOLECULAR THERAPY
- Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
- (2018) Folashade Otegbeye et al. PLoS One
- Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
- (2018) Nataliya Rohr-Udilova et al. Scientific Reports
- Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
- (2018) Thitinee Vanichapol et al. Biomed Research International
- Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
- (2018) Jodi Chiu et al. Frontiers in Immunology
- Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
- (2018) TOSHIHARU MURAKAMI et al. ANTICANCER RESEARCH
- Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells
- (2018) Masayuki Shiozawa et al. BMC IMMUNOLOGY
- Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy
- (2018) Elizabeth L. Siegler et al. Cell Stem Cell
- The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer
- (2018) Kazutake Okada et al. ONCOLOGY
- NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis
- (2018) Anahid Jewett et al. SEMINARS IN CANCER BIOLOGY
- Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
- (2018) Bin Han et al. Journal of Immunology Research
- PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
- (2018) Fernando Concha-Benavente et al. Cancer Immunology Research
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
- (2018) Jiao Wang et al. Journal for ImmunoTherapy of Cancer
- NK Cell-Based Glioblastoma Immunotherapy
- (2018) Irene Golán et al. Cancers
- Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy
- (2017) Rüdiger Klapdor et al. HUMAN GENE THERAPY
- Missing or altered self: human NK cell receptors that recognize HLA-C
- (2017) Hugo G. Hilton et al. IMMUNOGENETICS
- Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review
- (2017) Faiz Anwer et al. Immunotherapy
- Risk Factors and Preventions of Breast Cancer
- (2017) Yi-Sheng Sun et al. International Journal of Biological Sciences
- HER2-positive breast cancer
- (2017) Sibylle Loibl et al. LANCET
- EGFRvIII vaccine in glioblastoma—InACT-IVe or not ReACTive enough?
- (2017) Michael Platten NEURO-ONCOLOGY
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States
- (2017) Diarmuid Coughlan et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children
- (2017) Michael Merker et al. Oncotarget
- Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
- (2017) Qing Zhang et al. Journal of Immunology Research
- Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
- (2017) Jieming Zeng et al. Stem Cell Reports
- Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
- (2017) Anushruti Sarvaria et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Selection and expansion of natural killer cells for NK cell-based immunotherapy
- (2016) Petra S. A. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- (2016) Xiaojun Liu et al. CANCER RESEARCH
- A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
- (2016) Xilin Chen et al. Oncotarget
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
- (2015) Cheng Sun et al. ACTA PHARMACOLOGICA SINICA
- Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma
- (2015) Diana Seidel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
- (2015) Naoyuki Sakamoto et al. Journal of Translational Medicine
- Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
- (2015) Kurt Schönfeld et al. MOLECULAR THERAPY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
- (2015) Sabrina Genßler et al. OncoImmunology
- CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
- (2015) Jianfeng Han et al. Scientific Reports
- Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance
- (2014) D. Gotthardt et al. BLOOD
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific growth inhibition of ErbB2‑expressing human breast cancer cells by genetically modified NK‑92 cells
- (2014) Hui Liu et al. ONCOLOGY REPORTS
- Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Functional Natural Killer Cells In Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells
- (2014) Martha Luevano et al. PLoS One
- Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
- (2013) Theresa L. Whiteside BIOCHEMICAL SOCIETY TRANSACTIONS
- Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors
- (2013) R. Alkins et al. CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
- (2013) J. R. Webb et al. CLINICAL CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
- (2013) Z. Husain et al. JOURNAL OF IMMUNOLOGY
- Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma
- (2013) Tsutomu Nakazawa et al. JOURNAL OF NEURO-ONCOLOGY
- Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection
- (2013) Elisabeth Littwitz et al. Retrovirology
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
- (2012) Tolga Sutlu et al. HUMAN GENE THERAPY
- CAR–T cells and solid tumors: tuning T cells to challenge an inveterate foe
- (2012) David E. Gilham et al. TRENDS IN MOLECULAR MEDICINE
- Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
- (2011) M. Della Chiesa et al. BLOOD
- Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood
- (2011) J. G. Iyer et al. CLINICAL CANCER RESEARCH
- The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
- (2011) Martha Luevano et al. HUMAN IMMUNOLOGY
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
- (2011) Laurent Boissel et al. LEUKEMIA & LYMPHOMA
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Calming the cytokine storm
- (2010) Charlotte Harrison NATURE REVIEWS DRUG DISCOVERY
- Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ
- (2009) Kristopher Clark et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
- (2008) A. Kruschinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now